CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA

Purpose: To investigate the value of carcinoembryonic antigen (CEA) decline in predicting pathological tumor regression and outcome for locally advanced rectal cancer (LARC) patients who received neoadjuvant therapy with elevated baseline CEA. Methods: LARC patients with elevated pre-treatment CEA w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Zerong, Huang, Lingyu, Chen, Yufeng, Xie, Xiaoyu, Zou, Yifeng, Lan, Ping, Wu, Xiaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545678/
https://www.ncbi.nlm.nih.gov/pubmed/33046977
http://dx.doi.org/10.7150/jca.49252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545678/
https://www.ncbi.nlm.nih.gov/pubmed/33046977
http://dx.doi.org/10.7150/jca.49252

Ejemplares similares